X

pharmaceuticals

NATCO Pharma Limited (NATCOPHARM) Q3 FY23 Earnings Concall Transcript

NATCO Pharma Limited (NSE:NATCOPHARM) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Rajesh Chebiyam -- Executive Vice President of Crop…

ABBOTT INDIA LTD Ltd. (NSE: ABBOTTINDIA): Q3 FY23 Results Out; Total Income Rises 10% YoY

Abbott India Limited (NSE:ABBOTTINDIA) is a subsidiary of Abbott Laboratories, a multinational healthcare company. It was established in India in…

Alkem Laboratories Ltd. (NSE: ALKEM): Q3 FY23 Results Out; Total Income Rises 15% YoY

Alkem Laboratories Ltd.(NSE:ALKEM) is a pharmaceutical company that specializes in developing, manufacturing, and marketing of pharmaceutical and nutraceutical products. The…

JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q3 FY23 Earnings Concall Transcript

JB Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Q3 FY23 Earnings Concall dated Feb. 09, 2023. Corporate Participants: Jason D'Souza -- Vice President, Investor…

Piramal Pharma Ltd (PPLPHARMA) Q3 FY23 Earnings Concall Transcript

Piramal Pharma Ltd (NSE: PPLPHARMA) Q3 FY23 Earnings Concall dated Feb. 09, 2023 Corporate Participants: Gagan Borana -- General Manager, Investor Relations…

Earnings Summary Of Gland Pharma For Q3 FY23

Gland Pharma Limited (NSE: GLAND) is an Indian pharmaceutical company that specialises in producing high-quality, low-cost generic medications. The company…

Gland Pharma’s Acquisition Of Cenexi & Decline In Lead Product’s Market Share

Gland Pharma Limited (NSE: GLAND) is a major player in the Indian pharmaceutical market, specialising in the production and sale…

Piramal Enterprises Ltd Q3 FY23 Earnings Conference Call Insights

Key highlights from Piramal Enterprises Ltd (PEL) Q3 FY23 Earnings Concall Q&A Highlights: [00:16:30] Abhijit Tibrewal from Motilal Oswal asked…

Granules India Limited Q3 FY23; PAT Jumped Up To 124 Crore

Granules India Limited (NSE: GRANULES) reported Revenue from Operations for Q3 FY23 of ₹1,146.12 Crore up from ₹996.76 Crore year…

SUVEN PHARMACEUTICALS LTD (SUVEN) Q3 FY23 Earnings Concall Transcript

SUVEN PHARMACEUTICALS LTD (NSE:SUVEN) Q3 FY23 Earnings Concall dated Feb. 07, 2023. Corporate Participants: Rishab Barar -- Investor Relations Venkat Jasti -- Managing Director…